
Date: Oct 8, 2021 08:00 AM - 06:00 PM
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
SCSHP Fall Meeting 2021 (Virtual Conference)
Fri, Oct 08, 2021
Practice Advancement Initiative (PAI) 2030
- Discuss current trends and opportunities in pharmacy practice
- Recognize major themes associated with the PAI 2030 recommendations
- Explain PAI 2030 focused initiatives as indicators of progress toward adoption and implementation
- Define legislative/regulatory issues and advocacy efforts
- Identify the tools and resources available to implement PAI 2030 recommendations
Speaker(s)/Author(s)
|
Paul W. Bush, PharmD, MBA, BCPS, FASHP
|
Activity Number
0062-9999-21-157-L04-P/TCE Hours
CDI Guideline Update: A Pro/Con Debate
- Describe the burden of C. difficile on patients and the healthcare system
- Summarize the literature supporting the primary updates in the 2021 C. difficile infection (CDI) guidelines
- Determine the most appropriate therapeutic option for C. difficile, given a patient case
- Describe the burden of C. difficile on patients and the healthcare system
- Recognize therapeutic options for C. difficile
Speaker(s)/Author(s)
|
Aaron Hamby, PharmD, BCIDP
|
|
|
Rachel Burgoon, PharmD
|
Activity Number
0062-9999-21-158-L01-P/TCE Hours
You're Still on Mute: How to Navigate Professional Communication in the Virtual Community
- Identify appropriate etiquette to use when virtually communicating through email or other medias
- Prepare to actively participate in virtual interviews and meetings
- Apply tips and tricks on how to refine your professional brand and network virtually
Speaker(s)/Author(s)
|
Beju Shah, PharmD, MBA
|
|
|
Jaclyn Hawn, PharmD, BCCCP
|
Activity Number
0062-9999-21-159-L04-P/TCE Hours
Expired Medications: Debunking the Myths
- Identify potential barriers to extending expiration dates of prescription medications
Speaker(s)/Author(s)
|
Carrington Royals, PharmD
|
Activity Number
0062-9999-21-160-L01-P/TCE Hours
Clinical Skills Competition 2021
- Describe pharmacist impact on commonly encountered clinical scenarios
- Provide an example of appropriate continuity of care for commonly encountered clinical scenarios
- Recognize medication safety principles in commonly encountered clinical scenarios
- Describe the importance of utilizing evidence-based medicine in commonly encountered clinical scenarios
Activity Number
0062-9999-21-161-L01-P/TCE Hours
A Pharmacist Comes PrEPared: Applying the Evidence and Advocating for PrEP Therapy
- Interpret current guidelines and literature regarding the utility of PrEP therapy
- Apply current PrEP therapy recommendations to various patient cases
- Identify opportunities for pharmacists to advocate for PrEP in the community
- Recognize pharmacologic options for PrEP therapy
- Identify opportunities for pharmacy technicians to advocate for PrEP in the community
Speaker(s)/Author(s)
|
Kelsey Hamlin Furtick, PharmD
|
|
|
Stephen Asbill, PharmD, BCPS
|
Activity Number
0062-9999-21-162-L01-P/TCE Hours
Ready, Aim, Fire: Off-target Toxicity in Cancer Treatment
- Define off-target toxicity and differentiate it from other types of drug toxicity
- List 3 examples of off-target toxicity in cancer treatment
- Identify drug development techniques to mitigate off-target toxicity
- Recommend strategies for management of off-target toxicity
- Define off-target toxicity and differentiate it from other types of drug toxicity
- List 3 examples of off-target toxicity in cancer treatment
- Recognize pharmacologic and non-pharmacologic management strategies for off-target toxicity
Speaker(s)/Author(s)
|
Meredith Higley, PharmD, BCOP
|
Activity Number
0062-9999-21-163-L01-P/TCE Hours
Refreshing Look at PAMORAs
- Recognize peripherally acting μ-opioid receptor antagonists (PAMORAs) as a drug class
- Recall the mechanism of action of PAMORAs
- Discuss FDA-approved indications for use of PAMORAs
- Explain the use of PAMORAs in the perioperative setting and their impact on patient outcomes
- Identify the benefits of PAMORA choice in providing value to patients
Speaker(s)/Author(s)
|
Julie Cash, PharmD, BCCCP
|
|
|
Lloyd Sarbacker, PharmD, BCPS
|

